Breast cancers with high CD44 and low CD24 have been associated with the triple negative subtype (negative for estrogen receptor (ER), progesterone receptor (PR), and HER2 receptor) and with poorer prognosis [15, 16]. Here, ESR1 is linked to breast cancer.